Harvard Bioscience Inc. (NASDAQ: HBIO)
$2.0400
-0.0600 ( -3.32% ) 5.0K
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
Market Data
Open
$2.0400
Previous close
$2.1000
Volume
5.0K
Market cap
$91.59M
Day range
$2.0300 - $2.1200
52 week range
$1.9900 - $5.5600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Mar 07, 2024 |
8-k | 8K-related | 31 | Jan 05, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |